InvestorsHub Logo
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

Re: None

Monday, 02/09/2015 4:18:21 PM

Monday, February 09, 2015 4:18:21 PM

Post# of 53906
AMAG Pharmaceuticals EPS of $4.67

AMAG Pharmaceuticals (NASDAQ:AMAG): Q4 EPS of $4.67 may not be comparable to consensus of $0.30.
Revenue of $53.3M (+145.5% Y/Y) beats by $0.61M.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.